C. R. BARD, INC. (NYSE:BCR) Files An 8-K Submission of Matters to a Vote of Security Holders
Item5.07
|
Submission of Matters to a Vote of Security Holders. |
(a) The registrant held its Annual Meeting of Shareholders on
April19, 2017.
(b) Described below are the matters voted upon at the Annual
Meeting of Shareholders and the number of votes for and against,
abstentions and broker non-votes, as applicable.
Proposal No.1 Each of the 11 director nominees was
elected. The results of the voting for each director nominee for
a term of one year are set forth below:
|
Nominee |
Votes For | VotesAgainst | Abstain | BrokerNon-Votes | ||||||||||||||||
|
David M. Barrett |
58,325,877 | 352,121 | 53,846 | 4,731,155 | ||||||||||||||||
|
Robert M. Davis |
58,363,067 | 314,558 | 54,219 | 4,731,155 | ||||||||||||||||
|
Herbert L. Henkel |
56,308,859 | 2,378,722 | 44,263 | 4,731,155 | ||||||||||||||||
|
John C. Kelly |
58,496,992 | 192,046 | 42,806 | 4,731,155 | ||||||||||||||||
|
David F. Melcher |
58,049,317 | 639,077 | 43,450 | 4,731,155 | ||||||||||||||||
|
Gail K. Naughton |
57,661,030 | 1,030,224 | 40,590 | 4,731,155 | ||||||||||||||||
|
Timothy M. Ring |
55,557,823 | 2,143,438 | 1,030,583 | 4,731,155 | ||||||||||||||||
|
Tommy G. Thompson |
48,502,993 | 10,158,927 | 69,924 | 4,731,155 | ||||||||||||||||
|
John H. Weiland |
56,950,511 | 1,718,549 | 62,784 | 4,731,155 | ||||||||||||||||
|
Anthony Welters |
57,297,841 | 1,394,094 | 39,909 | 4,731,155 | ||||||||||||||||
|
Tony L. White |
55,291,377 | 3,366,467 | 74,000 | 4,731,155 |
Proposal No.2 Ratification of the appointment of KPMG LLP,
as the Companys independent registered public accounting firm for
fiscal year 2017 approved.
|
For |
62,301,017 | |||
|
Against |
1,085,353 | |||
|
Abstain |
76,629 |
Proposal No.3 Approval of the compensation of our named
executive officers, on an advisory basis approved.
|
For |
52,328,276 | |||
|
Against |
6,151,035 | |||
|
Abstain |
252,533 | |||
|
Broker non-votes |
4,731,155 |
Proposal No.4 Say-on-Pay Frequency advisory vote on the
approval of the frequency of shareholder votes on compensation of
our named executive officers One Year.
|
1 Year |
51,451,611 | |||
|
2 Years |
171,500 | |||
|
3 Years |
6,974,746 | |||
|
Abstain |
133,987 | |||
|
Broker non-votes |
4,731,155 |
The Company has considered these results and has determined that
it will hold an advisory vote to approve the compensation of its
named executive officers every year until the next required vote
on the frequency of advisory votes on the compensation of the
Companys named executive officers.
About C. R. BARD, INC. (NYSE:BCR)
C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs. C. R. BARD, INC. (NYSE:BCR) Recent Trading Information
C. R. BARD, INC. (NYSE:BCR) closed its last trading session up +0.69 at 254.77 with 653,276 shares trading hands.